View from the Thoraxcenter: ESC 2023 Preview

View from the Thoraxcenter: ESC 23 Late-breaking Science Preview

Average (ratings)

No ratings

•

Your rating

What is hot at ESC 2023?

In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.

Top trials presented at ESC Congress 2023 include:

00:31: ECLS-SHOCK: Extracorporeal life support in cardiogenic shock
03:25: EARLY-UNLOAD: Early left ventricular unloading after extracorporeal membrane oxygenation
05:21: ARREST: Expedited transfer to a cardiac arrest center for OHCA
07:33: GUIDE-DES: QCA versus IVUS guidance for DES implantation
10:38: ILUMIEN IV: OCT versus angiography
13:11: OCTOBER: OCT-guided or angiography-guided PCI in complex bifurcation lesions
16:14: OCTIVUS: OCT- versus IVUS-guided PCI
18:27: FIRE: Functional versus culprit-only revascularization in elderly patients with myocardial Infarction and multivessel disease
19:50: OCT vs IVUS vs Angiography Guidance
20:11: Meta-analysis of iFR-SWEDEHEART and DEFINE FLAIR
20:53: HEART-FID: Ferric carboxymaltose in heart failure with iron deficiency
22:14: STOPDAPT-3: An aspirin-free antithrombotic strategy for percutaneous coronary intervention
24:50: MULTISTARTS AMI: Multivessel immediate versus staged revascularization in STEMI
26:20: NOTION: The nordic aortic valve intervention trial

Mark your calendar for our ESC Congress coverage starting August 25th. Interviews, discussions, and insights live from Amsterdam.

Read MoreRead Less

Audio Video

Episodes

Up Next

View from the Thoraxcenter: ESC 23 Late-breaking Science Wrap Up

EP27 • Sep 06, 2023 • 47m 56s

In this ESC 2023 wrap-up, Prof Van Mieghem and Dr Daemen will dissect the data, evaluating real-world applicability, and distilling findings into actionable insights for clinical practice.

All Episodes

Ep 9: Sex Differences in Hypertension: Pharmacological Treatment

EP18 • Oct 31, 2022 • 25m 38s

In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations.

Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention

EP17 • Sep 30, 2022 • 23m 47s

What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?

In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.

Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention

EP16 • Sep 12, 2022 • 26m 25s

What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.

Ep 6: Inflammatory Biomarkers and Cardiovascular Risk

EP15 • Jun 29, 2022 • 28m 46s

What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?

Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data

EP14 • May 16, 2022 • 7m 25s

Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.

Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Targeting Inflammation in Atherosclerosis: Inflammation and Atherosclerosis

EP13 • May 13, 2022 • 8m 39s

Inflammation and Atherosclerosis – What is the Link with CKD? Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Lina Badimon (Hospital of Santa Creu and San Pau, Barcelona, Spain) as they discuss that very question.

Targeting Inflammation in Atherosclerosis: Therapeutic Targets and Mode of Action

EP12 • May 16, 2022 • 6m 42s

Prof Juan Carlos Kaski (St George’s University of London, UK) alongside Dr Peter Libby (Brigham and Women’s Hospital, Boston, US) provide us with a short and concise discussion regarding Therapeutic Targets and Mode of Action.

Targeting Inflammation in Atherosclerosis: Inflammatory Signalling in Atherosclerosis and CKD

EP11 • May 13, 2022 • 8m 36s

Inflammatory Signalling in Atherosclerosis and CKD is the topic of interest in this short peer to peer discussion involving Prof Juan Carlos Kaski (St George’s University of London, UK) and Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US).

Supported by an unrestricted educational grant from NOVO NORDISK A/S.

Targeting Inflammation in Atherosclerosis: Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease

EP10 • May 13, 2022 • 9m 50s

Prof Juan Carlos Kaski (St George’s University of London, UK) is joined by Prof Paul Ridker (Brigham and Women’s Hospital, Boston, US) to discuss Unmet Clinical Needs in Atherosclerosis and Chronic Kidney Disease where they cover topics such as elevated hsCRP and chronic kidney disease.

Targeting Inflammation in Atherosclerosis: COLCOT Trial

EP9 • Apr 22, 2022 • 5m 13s

Prof Jean-Claude Tardif (Montreal Heart Institute, Canada) gives us a comprehensive overview of the COLCOT trial.

1 2 3 4

... 2 3 4

View from the Thoraxcenter: EuroPCR 24 Preview

EP33 • May 07, 2024 • 26m 3s

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.

View from the Thoraxcenter: ACC.24 Wrap Up

EP32 • Apr 15, 2024 • 43m 48s

Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.

View from the Thoraxcenter: ACC.24 Late-breaking Science Preview

EP31 • Mar 25, 2024 • 28m 10s

What’s hot at ACC.24?

Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.

VHPSD versus Conventional Catheter Ablation in AF

Very-High Power Short Duration Vs Conventional Ablation for PVI in AF

EP30 • Dec 14, 2023 • 29m 53s

In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.

View from the Thoraxcenter: AHA 23 Wrap Up

View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

EP29 • Nov 20, 2023 • 23m 14s

Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023.
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.

1 2 3 4 5 6 ...

1 2 3 ...